Denmark medical cannabis sales post a positive quarter thanks to Epidiolex
A longer version of this story appears at Marijuana Business Daily International. Sales of medical marijuana in Denmark posted healthy gains in the third quarter of 2020, coinciding with the launch of GW Pharmaceuticals’ CBD drug Epidiolex. Overall sales of all medial cannabis products grew from about 13 million... Read more
Cannabis firm Canopy Growth sues GW Pharma, claiming patent infringement
(This story originally appeared at Marijuana Business Daily.) Canadian cannabis producer Canopy Growth Corp. is suing UK-based GW Pharmaceuticals in U.S. federal court, alleging that GW is knowingly infringing upon Canopy’s intellectual property. GW used a Canopy-patented method to extract the CBD that’s the active ingredient in its Epidiolex... Read more
Dutch biocontrols giant acquires Brazilian precision-farming firm
A Dutch biocontrols giant that has flexed into the cannabis space, Koppert Biological Systems, has acquired a Brazilian drone company in a bid to use drones to apply its sustainable biocontrols in Brazil. Koppert said its acquisition of Geocom will help it “accelerate precision agrifarming, which is crucial for... Read more
EU drug agency flags CBD market issues in report on low-THC cannabis products
The European Union’s drug agency has signaled that it is mulling the legal and commercial status of CBD and cannabis-based products in Europe in a new report. The Lisbon-based European Monitoring Centre for Drugs and Drug Addiction published the report on Monday, detailing the results of a study that... Read more
Italy finalizes hemp commission roster as industry eyes piece of 10 million-euro budget windfall
Italy’s agricultural ministry has named four dozen government, regulatory and industry stakeholders to  a new working group for the country’s hemp sector. According to a decree published last week, the working group is expected “to perform consultative and monitoring duties” for the hemp sector. The commission’s 48 members include representatives... Read more
Australia nixes prescription requirement for select CBD products
Regulators in Australia have amended the country’s drug law and removed a prescription requirement for some CBD products, paving the way for greater consumer access but saddling CBD makers with efficacy requirements that threaten to create barriers to market entry. The Therapeutic Goods Administration (TGA) said Tuesday it was... Read more
Mexico hits snooze on hemp legalization until next spring
The Supreme Court of Mexico has again extended the deadline for legislators to comply with a mandate to legalize industrial hemp and adult-use marijuana. Congress can now legislate on this matter until the end of the next ordinary session period, which starts in February 2021 and ends in April.... Read more
Canada’s Canopy Growth loans $20 million to hemp-CBD subsidiary of TerrAscend
Arise Bioscience, a Florida-based hemp-derived CBD subsidiary of TerrAscend Corp., has received a $20 million loan from Canada’s Canopy Growth. In exchange for the loan, TerrAscend, which makes prescription cannabinoids and is headquartered in Mississauga, Ontario, has issued 2,105,718 common share purchase warrants to Canopy Growth, according to a... Read more
Brazil postpones evaluation of CBD formulation for medical coverage
A version of this story originally appeared at Marijuana Business Daily International. A government evaluation to include a CBD product in Brazil’s Public Health System has been postponed. Brazil’s National Committee for Health Technology Incorporation had been scheduled to take up the question of covering the oral CBD product... Read more
Mexican Congress delays hemp bill debate, pushing approval into 2021
Get in-depth analysis on Latin America hemp and marijuana markets from MJBizCon’s Passholder Days. It’s all available to you on demand. The Mexican lower house has delayed a hemp and marijuana legalization bill until at least February. Local media reports that lawmakers say they need more time to study the bill.... Read more
( ) ( ) ( ) ( ) ( ) ( ) ( ) ( )